Cargando…

812. Case–Control Trial to Evaluate the Cytokine Response to the Use of Capsule Thalidomide in Erythema Nodosum Leprosum in Leprosy Patients

BACKGROUND: Leprosy is a chronic granulomatous disease caused by Mycobacterium leprae. Type II lepra reaction or Erythema Nodosum Leposum is a Type III hypersentivity immune response during the chronic course of the illness. This immune response presents as systemic symptoms and neutrophilic leukocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Ajay, Mitra, Debdeep, Mitra, Barnali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254824/
http://dx.doi.org/10.1093/ofid/ofy210.819

Ejemplares similares